251 related articles for article (PubMed ID: 7845310)
1. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
[TBL] [Abstract][Full Text] [Related]
2. [Long term study of the treatment with recombinant alfa 2b interferon in chronic active hepatitis due to B virus in children and adolescents].
Castañeda Guillot C; Escobar Capote MD; García Bacallao E; Borbolla Bousquets E
G E N; 1994; 48(4):219-25. PubMed ID: 7557276
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2b therapy in children with chronic hepatitis B.
Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
[TBL] [Abstract][Full Text] [Related]
5. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic viral hepatitis B in children with moderate doses of alpha interferon].
Cullu F; Tümay GT; Kutlu T; Erkan T; Ozbay G; Badur S
Gastroenterol Clin Biol; 1995 Jan; 19(1):53-7. PubMed ID: 7720991
[TBL] [Abstract][Full Text] [Related]
7. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
[TBL] [Abstract][Full Text] [Related]
8. Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course.
Reichard O; Glaumann H; Norkrans G; Wejstål R; Fryden A; Schvarcz R; Weiland O
Liver; 1994 Aug; 14(4):169-74. PubMed ID: 7526108
[TBL] [Abstract][Full Text] [Related]
9. Interferon treatment of chronic active hepatitis B: effect of a six month treatment regimen.
Raptopoulou M; Orphanou H; Vrettou H; Akribiadis E; Chadzikonstantinou L; Goulis G
Gut; 1993; 34(2 Suppl):S102-3. PubMed ID: 8314469
[TBL] [Abstract][Full Text] [Related]
10. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a long-term follow-up study.
Coppens JP; Cornu C; Lens E; Lamy M; Geubel AP
J Hepatol; 1990; 11 Suppl 1():S126-8. PubMed ID: 2079569
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
12. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic hepatitis D with interferon alfa-2a.
Farci P; Mandas A; Coiana A; Lai ME; Desmet V; Van Eyken P; Gibo Y; Caruso L; Scaccabarozzi S; Criscuolo D
N Engl J Med; 1994 Jan; 330(2):88-94. PubMed ID: 8259188
[TBL] [Abstract][Full Text] [Related]
14. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.
Poynard T; Bedossa P; Chevallier M; Mathurin P; Lemonnier C; Trepo C; Couzigou P; Payen JL; Sajus M; Costa JM
N Engl J Med; 1995 Jun; 332(22):1457-62. PubMed ID: 7739681
[TBL] [Abstract][Full Text] [Related]
15. Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis.
Perez V; Tanno H; Villamil F; Fay O
J Hepatol; 1990; 11 Suppl 1():S113-7. PubMed ID: 2079567
[TBL] [Abstract][Full Text] [Related]
16. Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study.
Realdi G; Fattovich G; Pastore G; Caredda F; Noventa F; Santantonio T; Moroni M; Criscuolo D; Maladorno D; Rugge M
J Hepatol; 1990; 11 Suppl 1():S129-32. PubMed ID: 2079570
[TBL] [Abstract][Full Text] [Related]
17. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of chronic hepatitis B with interferon alpha-2b].
Baumgarten R; Müller R; Markus R; Hintsche-Kilger B; Fengler JD; Meisel H
Gastroenterol J; 1990; 50(3):124-8. PubMed ID: 2288653
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study.
Robson SC; Brice E; van Rensburg C; Kannemeyer J; Hift RJ; Kirsch RE
S Afr Med J; 1992 Nov; 82(5):317-20. PubMed ID: 1448711
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant alpha interferon on chronic active hepatitis B: preliminary results.
Bayraktar Y; Uzunalimoglu B; Arslan S; Koseoglu T; Kayhan B; Telatar H
Gut; 1993; 34(2 Suppl):S101. PubMed ID: 8314468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
